tiprankstipranks
Trending News
More News >
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
US Market

Y-Mabs Therapeutics (YMAB) Ownership - Who Owns Y-Mabs Therapeutics?

Compare
516 Followers

Y-Mabs Therapeutics (YMAB) Ownership Overview

1.77%7.70%36.08%8.96%45.49%
36.08% Other Institutional Investors
8.96% ETFs
45.49% Public Companies and Individual Investors
The ownership structure of Y-Mabs Therapeutics (YMAB) stock is a mix of institutional, retail, and individual investors. Approximately 52.74% of the company’s stock is owned by Institutional Investors, 1.77% is owned by Insiders, and 45.49% is owned by Public Companies and Individual Investors.
The ownership structure of Y-Mabs Therapeutics (YMAB) stock is a mix of institutional, retail, and individual investors. Approximately 43.78% of the company’s stock is owned by Institutional Investors, 1.77% is owned by Insiders, and 8.96% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 11, 2025
xxxxxxxxxxxxx
$56536
Mar 11, 2025
xxxxxxxxxxxxx
$20368
Sep 17, 2024
xxxxxxxxxxxxx
$1264650
Aug 30, 2024
xxxxxxxxxxxxx
$768500

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$56057

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,860,562Institution4.11%8,763,247
1,646,587Institution3.64%7,755,425
1,540,964Institution3.40%7,257,940
433,402Insider0.96%2,041,323
397,193Institution0.88%1,870,779
338,227Institution0.75%1,593,049
220,831Institution0.49%1,040,114
209,064Institution0.46%984,691
188,163Institution0.42%886,248
173,813Institution0.38%818,659

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,540,964Institution3.40%7,257,940
397,193Institution0.88%1,870,779
338,227Institution0.75%1,593,049
220,831Institution0.49%1,040,114
209,064Institution0.46%984,691
188,163Institution0.42%886,248
104,853Institution0.23%493,858
98,087Institution0.22%461,990
55,000Institution0.12%259,050
44,474Institution0.10%209,473

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,040,061Institution2.30%4,420,259
923,492Institution2.04%4,349,647
500,903Institution1.11%2,128,838
311,228Institution0.69%1,465,884
208,800Institution0.46%983,448
185,832Institution0.41%789,786
156,367Institution0.35%723,979
96,625Institution0.21%410,656
76,083Institution0.17%358,351
69,367Institution0.15%321,169

FAQ

Who Owns Y-Mabs Therapeutics (YMAB)?
According to the latest TipRanks data, approximately 36.08% of the company's stock is held by institutional investors, 1.77% is held by insiders, and 45.49% is held by retail investors.
    What percentage of Y-Mabs Therapeutics (YMAB) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 36.08% of Y-Mabs Therapeutics (YMAB) stock is held by institutional investors.
      What percentage of Y-Mabs Therapeutics (YMAB) stock is held by retail investors?
      According to the latest TipRanks data, approximately 45.49% of Y-Mabs Therapeutics (YMAB) stock is held by retail investors.
        Who owns the most shares of Y-Mabs Therapeutics (YMAB)?
        Vanguard owns the most shares of Y-Mabs Therapeutics (YMAB).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis